The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients

被引:111
作者
Tomiyama, Cristianne
Higa, Andrea
Dalboni, Maria A.
Cendoroglo, Miguel
Draibe, Sergio A.
Cuppari, Lilian
Carvalho, Aluizio B.
Neto, Emilio M.
Canziani, Maria Eugenia F.
机构
[1] Univ Fed Sao Paulo, Dept Internal Med, Div Nephrol, Sao Paulo, Brazil
[2] Brazil Diagnost Ctr, Sao Paulo, Brazil
关键词
chronic kidney disease; coronary arteriosclerosis; multislice computed tomography; vascular calcification;
D O I
10.1093/ndt/gfl291
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Coronary heart disease (CHD) is the leading cause of death among end-stage renal disease patients. There is evidence that coronary calcification is a marker of atherosclerotic vascular disease and is predictive of cardiovascular events, especially in patients on renal replacement therapy. It has recently been suggested that CHD begins in the pre-dialysis period. However, data regarding coronary calcification in this population is scarce. This study was aimed at evaluating such coronary calcification and identifying related factors. Methods. A total of 96 chronic kidney disease out-patients who were not on dialysis were included. Patients presenting neoplastic, infectious or inflammatory diseases were excluded. Demographic characteristics, clinical profiles, laboratory test results and multislice computed tomography scans were evaluated. Results. The median age was 55 years (range 20-69 years), 67% were men and the median creatinine clearance was 37 ml/min/1.73 m(2). Coronary calcification, defined as a coronary artery calcification score (CACS) > 0 Agatston units (AU), was seen in 61 patients (median 89.1 AU, range 0.37-2299.3 AU). On average, these patients were older, more often had diabetes, higher body mass indices and higher Framingham risk indices, as well as presenting higher proteinuria, intact parathyroid hormone (iPTH), blood glucose and triglyceride levels compared with those without calcification. Multiple logistic regression analysis, adjusted for age and diabetes, identified iPTH and triglyceride levels as independent determinants of calcification. Severe calcification (CACS > 400 AU) was seen in 22 patients, who were also older and more frequently had a history of cardiovascular disease (CVD), as well as having higher levels of phosphorus, blood glucose and soluble Fas (sFas). Multiple logistic regression analysis, adjusted for age and diabetes, identified phosphorus and sFas levels as independent determinants of severe coronary calcification. Conclusion. Coronary calcification is highly prevalent in pre-dialysis patients and correlates with traditional and non-traditional risk factors for CVD.
引用
收藏
页码:2464 / 2471
页数:8
相关论文
共 42 条
[21]   Soluble fas is a marker of coronary artery disease in patients with end-stage renal disease [J].
Hébert, MJ ;
Masse, M ;
Vigneault, N ;
Sirois, I ;
Troyanov, S ;
Madore, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) :1271-1276
[22]   APOPTOSIS IN HUMAN ATHEROSCLEROSIS AND RESTENOSIS [J].
ISNER, JM ;
KEARNEY, M ;
BORTMAN, S ;
PASSERI, J .
CIRCULATION, 1995, 91 (11) :2703-2711
[23]   Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization [J].
Keith, DS ;
Nichols, GA ;
Gullion, CM ;
Brown, JB ;
Smith, DH .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (06) :659-663
[24]   Serum phosphate levels and mortality risk among people with chronic kidney disease [J].
Kestenbaum, B ;
Sampson, JN ;
Rudser, KD ;
Patterson, DJ ;
Seliger, SL ;
Young, B ;
Sherrard, DJ ;
Andress, DL .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :520-528
[25]   Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study [J].
Kramer, H ;
Toto, R ;
Peshock, R ;
Cooper, R ;
Victor, R .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :507-513
[26]   Changing concepts of atherogenesis [J].
Libby, P .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (03) :349-358
[27]   Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD) [J].
Moe, SM ;
Reslerova, M ;
Ketteler, M ;
O'Neill, K ;
Duan, DX ;
Koczman, J ;
Westenfeld, R ;
Jahnen-Dechent, W ;
Chen, NX .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2295-2304
[28]  
Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745
[29]  
*NAT KIDN FDN, 2003, AM J KIDNEY DIS, V42, pS12
[30]   Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure [J].
Perianayagam, MC ;
Murray, SL ;
Balakrishnan, VS ;
Guo, DQ ;
King, AJ ;
Pereira, BJG ;
Jaber, BL .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 136 (04) :320-327